Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury

Stem Cells and Development

Volumn 23, Issue 15, 2014, Pages 1809-1819

  Lindoso, Rafael S ^a,b,c   Collino, Federica ^a   Bruno, Stefania ^d   Araujo, Dayana S ^b,c   Sant'Anna, Julliana F ^b,c   Tetta, Ciro ^e   Provero, Paolo ^d,f   Quesenberry, Peter J ^g   Vieyra, Adalberto ^b,c   Einicker Lamas, Marcelo ^b,c   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c National Institute of Science and Technology for Structural Biology and Bioimaging   (Brazil)

^d UNIVERSITY OF TURIN   (Italy)

^e EMEA la Medical Board Fresenius Medical Care   (Germany)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 7; CELL ADHESION MOLECULE; MICRORNA; MICRORNA 100; MICRORNA 125B; MICRORNA 145; MICRORNA 19A 3P; MICRORNA 21; MICRORNA 222; MICRORNA 24; MICRORNA 99A; MICRORNA 99B; PROTEIN; SHC1 PROTEIN; SMAD4 PROTEIN; TRANSFER RNA; UNCLASSIFIED DRUG; BETA1 INTEGRIN; HERMES ANTIGEN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CYTOPLASM VESICLE; DOWN REGULATION; EPITHELIUM CELL; EXTRACELLULAR VESICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; UPREGULATION; CELL LINE; DEFICIENCY; GENE ONTOLOGY; GENETICS; KIDNEY TUBULE; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD29; ANTIGENS, CD44; CELL LINE; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; CYTOPROTECTION; EPITHELIAL CELLS; GENE ONTOLOGY; HUMANS; KIDNEY TUBULES; MESENCHYMAL STROMAL CELLS; MICRORNAS; UP-REGULATION;

EID: 84904694644     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0618     Document Type: Article

References (49)

1. Bussolati B, PV Hauser, R Carvalhosa and G Camussi. (2009). Contribution of stem cells to kidney repair. Curr Stem Cell Res Ther 4:2-8.
2. Asanuma H, DR Meldrum and KK Meldrum. (2010). Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 184:26-33.
3. Camussi G, MC Deregibus and C Tetta. (2010). Paracrine/endocrine mechanism of stem cells on kidney repair: Role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens 19:7-12.
4. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
5. Ratajczak J, K Miekus, M Kucia, J Zhang, R Reca, P Dvorak and MZ Ratajczak. (2006). Embryonic stem cellsderived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847-856.
6. Deregibus MC, V Cantaluppi, R Calogero, M Lo Iacono, C Tetta, L Biancone, S Bruno, B Bussolati and G Camussi. (2007). Endothelial progenitor cell-derived microvescicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448.
7. Collino F, MC Deregibus, S Bruno, L Sterpone, G Aghemo, L Viltono, C Tetta and G Camussi. (2010). Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5:e11803.
8. Quesenberry PJ, MS Dooner and JM Aliotta. (2010). Stem cell plasticity revisited: The continuum marrow model and phenotypic changes mediated by microvesicles. Exp Hematol 38:581-592.
9. Aliotta JM, M Pereira, M Li, A Amaral, A Sorokina, MS Dooner, EH Sears, K Brilliant, B Ramratnam, DC Hixson and PJ Quesenberry. (2012). Stable cell fate changes in marrow cells induced by lung-derived microvesicles. J Extracell Vesicles 16:1-10.
10. Raposo G andWStoorvogel. (2013). Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200:373-383.
11. Quesenberry PJ and JM Aliotta. (2010). Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev 62:1141-1148.
12. Bartel DP. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
13. Fonsato V, F Collino, MB Herrera, C Cavallari, MC Deregibus, B Cisterna, S Bruno, R Romagnoli, M Salizzoni, C Tetta and G Camussi. (2012). Human liver stem cellderived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 30:1985-1998.
14. Dagher PC. (2000). Modeling ischemia in vitro: Selective depletion of adenine and guanine nucleotide pools. Am J Physiol Cell Physiol 279:C1270-C1277.
15. Friedman RC, KK Farh, CB Burge and DP Bartel. (2009). Most mammalian mRNAs are conserved targets of micro-RNAs. Genome Res 19:92-105.
16. Schwartz JH, T Shih, SA Menza and W Lieberthal. (1999). ATP depletion increases tyrosine phosphorylation of betacatenin and plakoglobin in renal tubular cells. J Am Soc Nephrol 10:2297-2305.
17. Herrera MB, B Bussolati, S Bruno, V Fonsato, GM Romanazzi and G Camussi. (2004). Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035-1041.
18. Tögel F, Z Hu, K Weiss, J Isaac, C Lange and C Westenfelder. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42.
19. Morigi M, M Introna, B Imberti, D Corna, M Abbate, C Rota, D Rottoli, A Benigni, N Perico, et al. (2008). Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075-2082.
20. Beiral HJ, C Rodrigues-Ferreira, AM Fernandes, SR Gonsalez, NCMortari,CMTakiya,MMSorenson, C Figueiredo-Freitas, A Galina and A Vieyra. (2014). The impact of stem cells on electron fluxes, proton translocation and ATP synthesis in kidney mitochondria after ischemia/reperfusion. Cell Transplant 23:207-220.
21. Semedo P, M Correa-Costa, M Antonio Cenedeze, D Maria Avancini Costa Malheiros, M Antonia dos Reis, MH Shimizu, AC Seguro and A Pacheco-Silva. (2009). Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodelling properties in a rat remnant kidney model. Stem Cells 27:3063-3073.
22. Choi S, M Park, J Kim, S Hwang, S Park and Y Lee. (2009). The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18:521-529.
23. Choi SJ, JK Kim and SD Hwang. Mesenchymal stem cell therapy for chronic renal failure. Expert Opin Biol Ther 10:1217-1226.
24. Verdoorn KS, RS Lindoso, J Lowe, LS Lara, A Vieyra and M Einicker-Lamas. (2010). Bone marrow mononuclear cells shift bioactive lipid pattern in injured kidney towards tissue repair in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 25:3867-3874.
25. Lindoso RS, DS Araujo, J Adão-Novaes, RM Mariante, KS Verdoorn, L Fragel-Madeira, C Caruso-Neves, R Linden, A Vieyra and M Einicker-Lamas. (2011). Paracrine interaction between bone marrow-derived stem cells and renal epithelial cells. Cell Physiol Biochem 28:267-278.
26. Togel F, K Weiss, Y Yang, Z Hu, P Zhang and C Westenfelder. (2007). Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:F1626-F1635.
27. Bi B, R Schmitt, M Israilova, H Nishio and LG Cantley. (2007). Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496.
28. Tögel F, P Zhang, Z Hu and C Westenfelder. (2009). VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 13:2109-2114.
29. Bi B, J Guo, A Marlier, SR Lin and LG Cantley. (2008). Erythropoietin expands a stromal cell population that can mediate renoprotection. Am J Physiol Renal Physiol 295:F1017-F1022.
30. Cantaluppi V, L Biancone, GM Romanazzi, F Figliolini, S Beltramo, F Galimi, MG Camboni, E Deriu, P Conaldi, et al. (2008). Macrophage stimulating protein may promote tubular regeneration after acute injury. J Am Soc Nephrol 19:1904-1918.
31. Caplan AI and JE Dennis. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
32. Vogetseder A, N Picard, A Gaspert, M Walch, B Kaissling and M Le Hir. (2008). Proliferation capacity of the renal proximal tubule involves the bulk of differentiated epithelial cells. Am J Physiol Cell Physiol 294: C22-C28.
33. Gnecchi M, Z Zhang, A Ni and VJ Dzau. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219.
34. Herrera MB, V Fonsato, S Gatti, MC Deregibus, A Sordi, D Cantarella, R Calogero, B Bussolati, C Tetta and G Camussi. (2009). Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14:1605-1618.
35. Bruno S, C Grange, F Collino, MC Deregibus, V Cantaluppi, L Biancone, C Tetta and G Camussi. (2012). Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7:e33115.
36. Wei Q, K Bhatt, HZ He, QS Mi, VH Haase and Z Dong. (2010). Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 21:756-761
37. Godwin JG, X Ge, K Stephan, A Jurisch, SG Tullius and J Iacomini. (2010). Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 107:14339-14344.
38. Kaucsár T, C Révész, M Godó, T Krenács, M Albert, CI Szalay, L Rosivall, Z Benyó, S Bátkai, et al. (2013). Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury. Nucleic Acid Ther 23:344-354.
39. Saikumar J, D Hoffmann, TM Kim, VR Gonzalez, Q Zhang, PL Goering, RP Brown, V Bijol, PJ Park, SS Waikar and VS Vaidya. (2012). Expression, circulation, and excretion profile of microRNA-21,-155, and-18a following acute kidney injury. Toxicol Sci 129:256-267.
40. Kaushal GP, N Ueda and SV Shah. (1997). Role of caspases (ICE/CED 3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A. Kidney Int 52:438-445.
41. Edelstein CL, Y Shi and RW Schrier. (1999). Role of caspases in hypoxiainduced necrosis of rat renal proximal tubules. J Am Soc Nephrol 10:1940-1949.
42. Natalicchio A, F Tortosa, S Perrini, L Laviola and F Giorgino. (2011). p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress. Arch Physiol Biochem 117:116-124.
43. Orsini F, E Migliaccio, M Moroni, C Contursi, VA Raker, D Piccini, I Martin-Padura, G Pelliccia, M Trinei, et al. (2004). The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 279:25689-25695.
44. Natalicchio A, L Laviola, C De Tullio, LA Renna, C Montrone, S Perrini, G Valenti, G Procino, M Svelto and F Giorgino. (2004). Role of p66SHC isoform in IGF-I receptor signal through MEK/ERK and regulation of actin cytoskeleton in rat myoblasts. J Biol Chem 279:43900-43909.
45. Liu SF, SY Chang, TC Lee, LY Chuang, JY Guh, CY Hung, TJ Hung, YJ Hung, PY Chen, PF Hsieh and YL Yang. (2012). Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smad-and epithelial-mesenchymal transition signaling pathways. PLoS One 7:e47482.
46. Meng XM, XR Huang, J Xiao, AC Chung, W Qin, HY Chen and HY Lan. (2012). Disruption of Smad4 impairs TGF-b/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int 81:266-279.
47. Lan HY. (2011). Diverse roles of TGF-b/Smads in renal fibrosis and inflammation. Int J Biol Sci 7:1056-1067.
48. Verrecchia F, L Vindevoghel, RJ Lechleider, J Uitto, AB Roberts and A Mauviel. (2001). Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene 20:3332-3340.
49. Vindevoghel L, RJ Lechleider, A Kon, MP de Caestecker, J Uitto, AB Roberts and A Mauviel. (1998). SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci USA 95:14769-14774.